Highlights
NASDAQ: BGNE       Beigene Ltd Ads
Last Price Today's Change   Day's Range   Trading Volume
196.40   -0.90 (0.46%)  190.24 - 197.29  357,986

Overview

 
Avg Volume (4 weeks):459,935
4 Weeks Range:127.57 - 200.00
4 Weeks Price Volatility (%):
95.03%
52 Weeks Range:108.00 - 200.00
52 Weeks Price Volatility (%):
96.09%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

BeiGene Ltd is a United States based clinical-stage biopharmaceutical company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1.

  Be the first to like this.
 


 

2999  2600  389  2989 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 FCEL 0.889+0.079 
 CHK 0.69-0.012 
 CSCO 44.91-3.55 
 AMD 38.35+0.83 
 CPE 4.19-0.27 
 AABA 19.630.00 
 NIO 1.75-0.15 
 NOK 3.37-0.10 
 SNNA 0.27+0.11 
 BAC 32.70-0.09 
Partners & Brokers